Victory Capital Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-27,209
Closed -$142K 2597
2023
Q4
$142K Sell
27,209
-1,672
-6% -$8.75K ﹤0.01% 2285
2023
Q3
$455K Buy
28,881
+1
+0% +$16 ﹤0.01% 2016
2023
Q2
$561K Buy
28,880
+10,308
+56% +$200K ﹤0.01% 1931
2023
Q1
$527K Sell
18,572
-10,045
-35% -$285K ﹤0.01% 1984
2022
Q4
$836K Buy
28,617
+3,572
+14% +$104K ﹤0.01% 1822
2022
Q3
$662K Buy
25,045
+3,910
+19% +$103K ﹤0.01% 1923
2022
Q2
$939K Sell
21,135
-496
-2% -$22K ﹤0.01% 1777
2022
Q1
$955K Sell
21,631
-3,074
-12% -$136K ﹤0.01% 1838
2021
Q4
$1.26M Buy
24,705
+5,822
+31% +$296K ﹤0.01% 1732
2021
Q3
$1.05M Buy
18,883
+9,408
+99% +$525K ﹤0.01% 1840
2021
Q2
$406K Buy
9,475
+3,259
+52% +$140K ﹤0.01% 2303
2021
Q1
$259K Buy
+6,216
New +$259K ﹤0.01% 2451
2020
Q4
Sell
-6,255
Closed -$266K 2591
2020
Q3
$266K Sell
6,255
-400
-6% -$17K ﹤0.01% 2197
2020
Q2
$319K Sell
6,655
-8,797
-57% -$422K ﹤0.01% 2157
2020
Q1
$710K Buy
15,452
+3,866
+33% +$178K ﹤0.01% 1969
2019
Q4
$696K Buy
11,586
+4,828
+71% +$290K ﹤0.01% 1865
2019
Q3
$382K Buy
6,758
+5,033
+292% +$284K ﹤0.01% 1988
2019
Q2
$96K Sell
1,725
-3,002
-64% -$167K ﹤0.01% 1633
2019
Q1
$239K Sell
4,727
-104
-2% -$5.26K ﹤0.01% 1523
2018
Q4
$195K Sell
4,831
-506,519
-99% -$20.4M ﹤0.01% 1554
2018
Q3
$35.5M Sell
511,350
-155,184
-23% -$10.8M 0.07% 453
2018
Q2
$50.4M Sell
666,534
-352,149
-35% -$26.6M 0.11% 304
2018
Q1
$53.7M Sell
1,018,683
-31,484
-3% -$1.66M 0.12% 272
2017
Q4
$56.1M Buy
1,050,167
+72,217
+7% +$3.86M 0.12% 264
2017
Q3
$58.3M Buy
977,950
+9,571
+1% +$571K 0.13% 251
2017
Q2
$76.4M Sell
968,379
-104,335
-10% -$8.23M 0.18% 162
2017
Q1
$89M Buy
1,072,714
+209,398
+24% +$17.4M 0.21% 130
2016
Q4
$68.5M Buy
863,316
+173,056
+25% +$13.7M 0.17% 196
2016
Q3
$48.3M Buy
+690,260
New +$48.3M 0.14% 247